These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7013863)

  • 1. Prognostic knowledge: interest and methods.
    Chastang C; Auquier A; Gremy F
    Bull Cancer; 1980; 67(4):430-6. PubMed ID: 7013863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].
    Byar D; Chastang C
    Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical comparison of random allocation methods in cancer clinical trials.
    Hagino A; Hamada C; Yoshimura I; Ohashi Y; Sakamoto J; Nakazato H
    Control Clin Trials; 2004 Dec; 25(6):572-84. PubMed ID: 15588744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of prognostic factors in cancer clinical trials.
    Simon R
    Cancer Treat Rep; 1984 Jan; 68(1):185-92. PubMed ID: 6362863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designs for experiments--parallel comparisons of treatment.
    Lavori PW; Louis TA; Bailar JC; Polansky M
    N Engl J Med; 1983 Nov; 309(21):1291-9. PubMed ID: 6633587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in clinical cancer trials.
    Estey E
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2591-3. PubMed ID: 9815662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic lymphocytic leukemia. Is staging or prognostic grouping of chronic lymphocytic leukemia relevant to the choice of treatment?].
    Ly B
    Tidsskr Nor Laegeforen; 1985 Oct; 105(29):2066-9. PubMed ID: 4071498
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized clinical trials. Perspectives on some recent ideas.
    Byar DP; Simon RM; Friedewald WT; Schlesselman JJ; DeMets DL; Ellenberg JH; Gail MH; Ware JH
    N Engl J Med; 1976 Jul; 295(2):74-80. PubMed ID: 775331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
    Byrd JC; Gribben JG; Peterson BL; Grever MR; Lozanski G; Lucas DM; Lampson B; Larson RA; Caligiuri MA; Heerema NA
    J Clin Oncol; 2006 Jan; 24(3):437-43. PubMed ID: 16344317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benchmarking the clinical prosthetic dental literature on MEDLINE.
    Nishimura K; Rasool F; Ferguson MB; Sobel M; Niederman R
    J Prosthet Dent; 2002 Nov; 88(5):533-41. PubMed ID: 12474005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
    Molica S
    Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
    Molica S; De Rossi G; Luciani M; Levato D
    Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Various randomized designs can be used to evaluate medical tests.
    Lijmer JG; Bossuyt PM
    J Clin Epidemiol; 2009 Apr; 62(4):364-73. PubMed ID: 18945590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient heterogeneity in clinical trials.
    Simon R
    Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimedia educational aids for improving consumer knowledge about illness management and treatment decisions: a review of randomized controlled trials.
    Jeste DV; Dunn LB; Folsom DP; Zisook D
    J Psychiatr Res; 2008 Jan; 42(1):1-21. PubMed ID: 17275026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.